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Primary biliary cirrhosis (PBC), although an uncommon disorder, has been described in most ethnic groups and nationalities. Studies of prevalence in different countries and regions have generated widely varying results,1-7 ranging from <10 to 154 per million of the population (Table) . This has led to the suggestion that an environmental agent may be an aetiological factor in PBC, and that this may be more important than genetic predisposition.1 [8] [9] [10] This study, conducted in the state of Victoria, is the first to examine PBC prevalence in Australia. Victoria is the second most populous Australian state (4.39 million people). From In the first phase of the study we wrote to all consultant physicians in Victoria who were thought likely to be caring for, or to have been consulted on, patients with PBC. These comprised all hospital specialist physicians with an interest in hepatology, gastroenterology, or rheumatology, and all general physicians. A total of 216 consultants were contacted. A further survey of Victorian dermatologists at their regular regional meeting identified only three cases, all of whom had already been identified in the first phase of the study.
In the initial mail survey doctors were asked if they had had any PBC patients under their care in the period 1.11.90 Clinical information at the time of diagnosis was available for 76 of the 84 patients. Twenty seven (36%) were asymptomatic at diagnosis and had been detected because of abnormal liver function tests. All except three of these patients remained well at the time of the survey, a mean of 4.5 years later (range 1-13). Forty nine patients (64%) were symptomatic at diagnosis and had presented on average 3.5 years (range 1-14) before the survey. At the time of the survey most of these patients were described as stable but six had deteriorated and five were described as ill.
PREVALENCE IN RACLAL GROUPS
Of the 84 cases, those born in Australia comprised 58% of the total (n=49), immigrants from the UK and Ireland 16% (n= 13), and patients from the rest of the world 26% (n=22; Germany 2 patients, Greece 3, The prevalence among immigrants from the UK and Ireland was significantly higher than in the Australian born population, and immigrants from the rest of the world (p<0.0002). There is, however, a noticeable difference in age distribution of Australian born people compared with UK and Ireland immigrants. After correction for age, the differences in prevalence between the Australian born population and UK and Ireland immigrants were no longer statistically significant (p= 0.12).
AGE SPECIFIC PREVALENCE
The youngest patient with PBC was aged 38 years. In the Australian born population the prevalence rate in the at risk group for PBC (that is, women >24 years) was 51 per million (95% CI 37.5, 67.9). In these Australian born women the prevalences in the age groups <35, 35-44, 45-54, 55-64, and >64 were 0, 40, 38, 81, and 122 per million respectively. We considered that numbers were too small in the immigrant groups to calculate the age specific prevalence.
Discussion
The overall prevalence of PBC in the Victorian population, 19.1 cases per million, is among the lowest recorded (Table) . It is similar to the prevalence of PBC in Ontario (22-4 definite cases per million), but well below the figures reported from northern Europe and the UK (54-154 definite cases per million) (Table) .
The approach to case ascertainment used in this study was similar to that used by WittSullivan et al6 in Ontario, Canada, in that individual specialists likely to have cared for PBC patients were contacted by mail and, where necessary, by telephone. We also examined the records of all the major teaching hospitals over an appropriate period, and this yielded a further 25 patients. We did not have the opportunity to seek out all patients with positive anti-mitochondrial antibody tests in Victoria over this period, since, unlike the position in the UK where there are regional immunology laboratories,l 5 there is no reference laboratory for the state to which all such immunological tests are sent. While this might have meant that some cases of PBC were not included in our study, it was reassuring that the survey of anti-mitochondrial antibody results in two teaching hospitals over the 10 year period 1980-89 yielded no extra cases of PBC. The virtually complete (98%) response rate from physicians who were contacted provided further reassurance that we were unlikely to have missed a significant number of cases. Thirty six per cent of cases in the present study were asymptomatic at the time of diagnosis. This is very similar to the studies in the north east of England (32%),5 Sweden (37%),7 and Canada (290/o).6 It is therefore unlikely that there was significant under-reporting of asymptomatic cases in our study.
Most of the data on the epidemiology of PBC come from studies conducted in European countries. The data in the Table  show Because there has been a large intake of migrants from the UK to Victoria in the past 50 years, this study also allowed us to examine the potential impact of a change of environment on expression of the disease. If environmental factors that favour the development of PBC are absent in Australia, immigrants might be expected to have a reduced prevalence of PBC compared to that in their native country. The current study indicates that this might be the case. The prevalence of PBC in female UK immigrants to Victoria aged greater than 24 years was 103 per million (53.4-180.7) compared to a prevalence of 276 per million in women aged greater than 18 living in England.5 Although the confidence limits for the prevalences in the immigrant population indicate significant differences from the UK population, the immigrant group is relatively small and this necessarily makes statistical comparisons subject to uncertainty.
It will be of interest to extend this study to the rest of Australia and to repeat the present study in the future to determine whether the differences in prevalence are maintained between Australian and European populations. There is evidence that the aetiology of PBC could be partly environmental, perhaps related to an infectious agent.'0 The current study supports the environmental notion and, if confirmed by future Australian studies, may prove to be an important pointer to a better understanding of the condition.
